Tapewire

Nasdaq · USD

RKDA

Arcadia Biosciences, Inc.

Export transactions ↓
Tapewire entity
8593
SEC CIK
0001469443
Parsed reports
133

Last 12 months

Inside the activity.

0 purchase rows · 0 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
June 02, 2021 Filed Jun 4, 2021 20:10 UTC GrantStock Option (right to buy) · Derivative 10,935 $0.00 Strike: $2.89 $0.00
Disclosure

SEC source: 0001209191-21-038196 · doc4.xml · derivative · entry 1

Carosella Deborah D · CIK 0001701600 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 32,788

Underlying: Common Stock · 10,935 shares

Expires 2031-06-02

F1 · derivative.exercise_date: The Option will become 100% vested and exercisable on the earlier to occur of (i) June 2, 2022 or (ii) the date of the Issuer's next Annual Meeting of Stockholders, subject to the Participant's continued service.

Read SEC document
June 02, 2021 Filed Jun 4, 2021 20:14 UTC GrantStock Option (right to buy) · Derivative 10,935 $0.00 Strike: $2.89 $0.00
Disclosure

SEC source: 0001209191-21-038203 · doc4.xml · derivative · entry 1

Murray Lilian Shackelford · CIK 0001743173 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,145

Underlying: Common Stock · 10,935 shares

Expires 2031-06-02

F1 · derivative.exercise_date: The Option will become 100% vested and exercisable on the earlier to occur of (i) June 2, 2022 or (ii) the date of the Issuer's next Annual Meeting of Stockholders, subject to the Participant's continued service.

Read SEC document
June 02, 2021 Filed Jun 4, 2021 19:59 UTC GrantStock Option (right to buy) · Derivative 10,935 $0.00 Strike: $2.89 $0.00
Disclosure

SEC source: 0001209191-21-038167 · doc4.xml · derivative · entry 1

WALLER GREGORY D · CIK 0001204144 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 36,157

Underlying: Common Stock · 10,935 shares

Expires 2031-06-02

F1 · derivative.exercise_date: The Option will become 100% vested and exercisable on the earlier to occur of (i) June 2, 2022 or (ii) the date of the Issuer's next Annual Meeting of Stockholders, subject to the Participant's continued service.

Read SEC document
May 17, 2021 Filed May 20, 2021 16:38 UTC
Cuvelier ChrisChief Growth Officer
GrantStock Option (right to buy) · Derivative 100,000 $0.00 Strike: $2.61 $0.00
Disclosure

SEC source: 0001209191-21-034432 · doc4.xml · derivative · entry 1

Cuvelier Chris · CIK 0001863255 · Chief Growth Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 100,000

Underlying: Common Stock · 100,000 shares

Expires 2031-05-17

F1 · derivative.exercise_date: 25% of the total number of shares subject to the Option will vest on the first anniversary of the date of the award; the remaining 75% will vest in 36 equal installments, subject to the Participant's continued service.

Read SEC document
February 22, 2021 Filed Feb 24, 2021 21:23 UTC GrantStock Option (right to buy) · Derivative 21,853 $0.00 Strike: $3.25 $0.00
Disclosure

SEC source: 0001209191-21-013784 · doc4.xml · derivative · entry 1

Carosella Deborah D · CIK 0001701600 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,853

Underlying: Common Stock · 21,853 shares

Expires 2031-02-22

F1 · derivative.exercise_date: The shares subject to the Option shall vest and become exercisable in three (3) equal annual installments, with one-third of the shares subject to the Option vesting on each of the first three (3) anniversaries of the date of the award, subject to the Participant's continued service through each applicable vesting date.

Read SEC document
January 21, 2021 Filed Jan 25, 2021 18:47 UTC
Shultz RandallChief Technology Officer
GrantStock Option (right to buy) · Derivative 55,000 $0.00 Strike: $3.05 $0.00
Disclosure

SEC source: 0001209191-21-005218 · doc4.xml · derivative · entry 2

Shultz Randall · CIK 0001808500 · Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 115,000

Underlying: Common Stock · 55,000 shares

Expires 2031-01-21

F2 · derivative.exercise_date: The options will vest monthly in equal installments over a period of four years from the date of the grant, 01/21/2021, subject to the Participant's continued service.

Read SEC document
January 21, 2021 Filed Jan 25, 2021 23:51 UTC
Plavan Matthew TChief Executive Officer
GrantStock Option (right to buy) · Derivative 250,000 $0.00 Strike: $3.05 $0.00
Disclosure

SEC source: 0001209191-21-005219 · doc4.xml · derivative · entry 2

Plavan Matthew T · CIK 0001326765 · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 435,450

Underlying: Common Stock · 250,000 shares

Expires 2031-01-21

F2 · derivative.exercise_date: The options will vest monthly in equal installments over a period of four years from the date of the grant, 01/21/2021, subject to the Participant's continued service.

Read SEC document
January 21, 2021 Filed Jan 25, 2021 23:43 UTC
Haley PamelaChief Financial Officer
GrantStock Option (right to buy) · Derivative 85,000 $0.00 Strike: $3.05 $0.00
Disclosure

SEC source: 0001209191-21-005213 · doc4.xml · derivative · entry 2

Haley Pamela · CIK 0001787373 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 144,313

Underlying: Common Stock · 85,000 shares

Expires 2031-01-21

F2 · derivative.exercise_date: The options will vest monthly in equal installments over a period of four years from the date of the grant, 01/21/2021, subject to the Participant's continued service.

Read SEC document
August 03, 2020 Filed Jan 25, 2021 18:47 UTC
Shultz RandallChief Technology Officer
PurchaseCommon Stock 700 $3.16 $2,212.00
Disclosure

SEC source: 0001209191-21-005218 · doc4.xml · nonDerivative · entry 1

Shultz Randall · CIK 0001808500 · Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,000

F1 · shares: Reflects the purchase of 700 shares of the Issuer's Common Stock on 8/3/20 at a per share purchase price of $3.16 pursuant to participation in the Issuer's 2015 Employee Stock Purchase Plan.

Read SEC document
August 03, 2020 Filed Jan 25, 2021 23:51 UTC
Plavan Matthew TChief Executive Officer
PurchaseCommon Stock 585 $3.16 $1,848.60
Disclosure

SEC source: 0001209191-21-005219 · doc4.xml · nonDerivative · entry 1

Plavan Matthew T · CIK 0001326765 · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,285

F1 · shares: Reflects the purchase of 585 shares of the Issuer's Common Stock on 8/3/20 at a per share purchase price of $3.16 pursuant to participation in the Issuer's 2015 Employee Stock Purchase Plan.

Read SEC document
August 03, 2020 Filed Jan 25, 2021 23:43 UTC
Haley PamelaChief Financial Officer
PurchaseCommon Stock 700 $3.16 $2,212.00
Disclosure

SEC source: 0001209191-21-005213 · doc4.xml · nonDerivative · entry 1

Haley Pamela · CIK 0001787373 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,638

F1 · shares: Reflects the purchase of 700 shares of the Issuer's common stock on 8/3/20 at a per share purchase price of $3.16 pursuant to participation in the Issuer's 2015 Employee Stock Purchase Plan.

Read SEC document
July 08, 2020 Filed Jul 10, 2020 13:20 UTC GrantStock Option (right to buy) · Derivative 5,273 $0.00 Strike: $3.73 $0.00
Disclosure

SEC source: 0001209191-20-042125 · doc4.xml · derivative · entry 1

Comcowich Kevin · CIK 0001688770 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 55,610

Underlying: Common Stock · 5,273 shares

Expires 2030-07-08

F1 · date: The Option will become 100% vested and exercisable on July 8, 2021.

F1 · derivative.exercise_date: The Option will become 100% vested and exercisable on July 8, 2021.

Read SEC document
July 08, 2020 Filed Jul 10, 2020 17:19 UTC GrantStock Option (right to buy) · Derivative 753 $0.00 Strike: $3.73 $0.00
Disclosure

SEC source: 0001209191-20-042124 · doc4.xml · derivative · entry 1

Murray Lilian Shackelford · CIK 0001743173 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,210

Underlying: Common Stock · 753 shares

Expires 2030-07-08

F1 · date: The Option will become 100% vested and exercisable on July 8, 2021.

F1 · derivative.exercise_date: The Option will become 100% vested and exercisable on July 8, 2021.

Read SEC document
June 01, 2020 Filed Jun 3, 2020 11:11 UTC GrantStock Option (right to buy) · Derivative 21,320 $0.00 Strike: $3.69 $0.00
Disclosure

SEC source: 0001209191-20-033826 · doc4.xml · derivative · entry 1

Comcowich Kevin · CIK 0001688770 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,338

Underlying: Common Stock · 21,320 shares

Expires 2030-06-01

F1 · derivative.exercise_date: The Option will become 100% vested and exercisable on the earlier to occur of (i) June 1, 2021 or (ii) the date of the Issuer's next Annual Meeting of Stockholders, subject to the Participant's continued service.

Read SEC document
June 01, 2020 Filed Jun 3, 2020 15:10 UTC GrantStock Option (right to buy) · Derivative 9,137 $0.00 Strike: $3.69 $0.00
Disclosure

SEC source: 0001209191-20-033825 · doc4.xml · derivative · entry 1

Bolles Albert D. · CIK 0001603163 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,463

Underlying: Common Stock · 9,137 shares

Expires 2030-06-01

F1 · derivative.exercise_date: The Option will become 100% vested and exercisable on the earlier to occur of (i) June 1, 2021 or (ii) the date of the Issuer's next Annual Meeting of Stockholders, subject to the Participant's continued service.

Read SEC document
June 01, 2020 Filed Jun 3, 2020 15:13 UTC
Yoder AmyDirector
GrantStock Option (right to buy) · Derivative 9,137 $0.00 Strike: $3.69 $0.00
Disclosure

SEC source: 0001209191-20-033828 · doc4.xml · derivative · entry 1

Yoder Amy · CIK 0001402263 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 29,376

Underlying: Common Stock · 9,137 shares

Expires 2030-06-01

F1 · derivative.exercise_date: The Option will become 100% vested and exercisable on the earlier to occur of (i) June 1, 2021 or (ii) the date of the Issuer's next Annual Meeting of Stockholders, subject to the Participant's continued service.

Read SEC document
June 01, 2020 Filed Jun 3, 2020 15:12 UTC GrantStock Option (right to buy) · Derivative 9,137 $0.00 Strike: $3.69 $0.00
Disclosure

SEC source: 0001209191-20-033827 · doc4.xml · derivative · entry 1

Murray Lilian Shackelford · CIK 0001743173 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,457

Underlying: Common Stock · 9,137 shares

Expires 2030-06-01

F1 · derivative.exercise_date: The Option will become 100% vested and exercisable on the earlier to occur of (i) June 1, 2021 or (ii) the date of the Issuer's next Annual Meeting of Stockholders, subject to the Participant's continued service.

Read SEC document
June 01, 2020 Filed Jun 3, 2020 15:09 UTC GrantStock Option (right to buy) · Derivative 9,137 $0.00 Strike: $3.69 $0.00
Disclosure

SEC source: 0001209191-20-033824 · doc4.xml · derivative · entry 1

WALLER GREGORY D · CIK 0001204144 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,222

Underlying: Common Stock · 9,137 shares

Expires 2030-06-01

F1 · derivative.exercise_date: The Option will become 100% vested and exercisable on the earlier to occur of (i) June 1, 2021 or (ii) the date of the Issuer's next Annual Meeting of Stockholders, subject to the Participant's continued service.

Read SEC document
April 01, 2020 Filed Apr 3, 2020 17:31 UTC
Shultz RandallChief Technology Officer
GrantStock Option (Right to Buy) · Derivative 18,000 $0.00 Strike: $2.74 $0.00
Disclosure

SEC source: 0001209191-20-023345 · doc4.xml · derivative · entry 1

Shultz Randall · CIK 0001808500 · Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 60,000

Underlying: Common Stock · 18,000 shares

Expires 2030-04-01

F1 · derivative.exercise_date: The option vests in 48 equal installments beginning April 30, 2020 and ending March 31, 2024.

Read SEC document
February 03, 2020 Filed Feb 4, 2020 21:14 UTC
Haley PamelaChief Financial Officer
GrantStock Option (right to buy) · Derivative 40,000 $0.00 Strike: $4.91 $0.00
Disclosure

SEC source: 0001209191-20-006294 · doc4.xml · derivative · entry 2

Haley Pamela · CIK 0001787373 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 58,588

Underlying: Common Stock · 40,000 shares

Expires 2030-02-03

F2 · derivative.exercise_date: The option vests in 48 equal installments beginning February 29, 2020 and ending January 31, 2024.

Read SEC document
February 03, 2020 Filed Feb 4, 2020 21:14 UTC
Haley PamelaChief Financial Officer
PurchaseCommon Stock 700 $1.72 $1,204.00
Disclosure

SEC source: 0001209191-20-006294 · doc4.xml · nonDerivative · entry 1

Haley Pamela · CIK 0001787373 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,938

F1 · shares: Reflects the purchase of 700 shares of the Issuer's common stock on 2/3/20 at a per share purchase price of $1.72 pursuant to participation in the Issuer's 2015 Employee Stock Purchase Plan.

Read SEC document
February 03, 2020 Filed Feb 4, 2020 21:13 UTC
Reiter SarahChief Commercial Officer
GrantStock Option (right to buy) · Derivative 50,000 $0.00 Strike: $4.91 $0.00
Disclosure

SEC source: 0001209191-20-006290 · doc4.xml · derivative · entry 2

Reiter Sarah · CIK 0001734605 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 121,705

Underlying: Common Stock · 50,000 shares

Expires 2030-02-03

F2 · derivative.exercise_date: The option vests in 48 equal installments beginning February 29, 2020 and ending January 31, 2024.

Read SEC document
February 03, 2020 Filed Feb 4, 2020 21:13 UTC
Reiter SarahChief Commercial Officer
PurchaseCommon Stock 700 $1.72 $1,204.00
Disclosure

SEC source: 0001209191-20-006290 · doc4.xml · nonDerivative · entry 1

Reiter Sarah · CIK 0001734605 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,800

F1 · shares: Reflects the purchase of 700 shares of the Issuer's common stock on 2/3/20 at a per share purchase price of $1.72 pursuant to participation in the Issuer's 2015 Employee Stock Purchase Plan.

Read SEC document
February 03, 2020 Filed Feb 4, 2020 21:11 UTC
Plavan Matthew TChief Executive Officer
GrantStock Option (right to buy) · Derivative 76,000 $0.00 Strike: $4.91 $0.00
Disclosure

SEC source: 0001209191-20-006282 · doc4.xml · derivative · entry 2

Plavan Matthew T · CIK 0001326765 · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 185,450

Underlying: Common Stock · 76,000 shares

Expires 2030-02-03

F2 · derivative.exercise_date: The option vests in 48 equal installments beginning February 29, 2020 and ending January 31, 2024.

Read SEC document
February 03, 2020 Filed Feb 4, 2020 21:11 UTC
Plavan Matthew TChief Executive Officer
PurchaseCommon Stock 700 $1.72 $1,204.00
Disclosure

SEC source: 0001209191-20-006282 · doc4.xml · nonDerivative · entry 1

Plavan Matthew T · CIK 0001326765 · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,700

F1 · shares: Reflects the purchase of 700 shares of the Issuer's common stock on 2/3/20 at a per share purchase price of $1.72 pursuant to participation in the Issuer's 2015 Employee Stock Purchase Plan.

Read SEC document
December 23, 2019 Filed Dec 23, 2019 21:50 UTC
Reiter SarahChief Commercial Officer
PurchaseCommon Stock 900 $5.95 $5,355.00
Disclosure

SEC source: 0001209191-19-061814 · doc4.xml · nonDerivative · entry 1

Reiter Sarah · CIK 0001734605 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,100

Read SEC document
November 19, 2019 Filed Nov 20, 2019 14:00 UTC
Reiter SarahChief Commercial Officer
PurchaseCommon Stock 1,000 $4.52 $4,520.00
Disclosure

SEC source: 0001209191-19-057375 · doc4.xml · nonDerivative · entry 1

Reiter Sarah · CIK 0001734605 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,200

Read SEC document
November 18, 2019 Filed Nov 19, 2019 15:50 UTC PurchaseCommon stock 5,000 $4.25 $21,250.00
Disclosure

SEC source: 0001209191-19-057084 · doc4.xml · nonDerivative · entry 1

Murray Lilian Shackelford · CIK 0001743173 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,524

Read SEC document
November 14, 2019 Filed Nov 18, 2019 18:32 UTC
Plavan Matthew TChief Executive Officer
PurchaseCommon stock 1,000 $4.08 $4,079.50
Disclosure

SEC source: 0001209191-19-056884 · doc4.xml · nonDerivative · entry 1

Plavan Matthew T · CIK 0001326765 · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,000

Read SEC document
September 23, 2019 Filed Sep 23, 2019 23:18 UTC
Plavan Matthew TChief Executive Officer
PurchaseCommon Stock 2,000 $5.25 $10,500.00
Disclosure

SEC source: 0001209191-19-050493 · doc4.xml · nonDerivative · entry 1

Plavan Matthew T · CIK 0001326765 · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,000

Read SEC document
September 17, 2019 Filed Sep 17, 2019 19:54 UTC PurchaseCommon Stock 5,000 $5.88 $29,388.00
Disclosure

SEC source: 0001209191-19-049954 · doc4.xml · nonDerivative · entry 1

Comcowich Kevin · CIK 0001688770 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,000

Read SEC document
September 10, 2019 Filed Sep 10, 2019 17:57 UTC PurchaseCommon Stock 10,000 $6.49 $64,900.00
Disclosure

SEC source: 0001209191-19-049067 · doc4.xml · nonDerivative · entry 2

Comcowich Kevin · CIK 0001688770 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,000

Read SEC document
September 10, 2019 Filed Sep 10, 2019 17:57 UTC PurchaseCommon Stock 5,000 $6.49 $32,433.00
Disclosure

SEC source: 0001209191-19-049067 · doc4.xml · nonDerivative · entry 1

Comcowich Kevin · CIK 0001688770 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,000

Read SEC document
September 10, 2019 Filed Sep 10, 2019 22:24 UTC
Plavan Matthew TChief Executive Officer
PurchaseCommon Stock 1,000 $6.52 $6,520.50
Disclosure

SEC source: 0001209191-19-049077 · doc4.xml · nonDerivative · entry 2

Plavan Matthew T · CIK 0001326765 · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,000

Read SEC document
September 10, 2019 Filed Sep 10, 2019 22:24 UTC
Plavan Matthew TChief Executive Officer
PurchaseCommon Stock 1,000 $6.49 $6,493.00
Disclosure

SEC source: 0001209191-19-049077 · doc4.xml · nonDerivative · entry 1

Plavan Matthew T · CIK 0001326765 · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,000

Read SEC document
September 10, 2019 Filed Sep 10, 2019 22:02 UTC
Reiter SarahChief Commercial Officer
PurchaseCommon Stock 1,200 $6.48 $7,776.00
Disclosure

SEC source: 0001209191-19-049070 · doc4.xml · nonDerivative · entry 1

Reiter Sarah · CIK 0001734605 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,200

Read SEC document
August 28, 2019 Filed Aug 28, 2019 17:01 UTC Amendment
Plavan Matthew TChief Financial Officer
PurchaseCommon Stock 1,000 $6.88 $6,880.00
Disclosure

SEC source: 0001209191-19-047582 · doc4a.xml · nonDerivative · entry 7

Plavan Matthew T · CIK 0001326765 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,000

Read SEC document
August 28, 2019 Filed Aug 28, 2019 14:31 UTC
Plavan Matthew TChief Financial Officer
GrantCommon Stock 1,000 $6.88 $6,880.00
Disclosure

SEC source: 0001209191-19-047580 · doc4.xml · nonDerivative · entry 7

Plavan Matthew T · CIK 0001326765 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,000

Read SEC document
August 27, 2019 Filed Aug 28, 2019 17:01 UTC Amendment
Plavan Matthew TChief Financial Officer
PurchaseCommon Stock 2,000 $8.93 $17,860.00
Disclosure

SEC source: 0001209191-19-047582 · doc4a.xml · nonDerivative · entry 6

Plavan Matthew T · CIK 0001326765 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,000

Read SEC document
August 27, 2019 Filed Aug 28, 2019 17:01 UTC Amendment
Plavan Matthew TChief Financial Officer
PurchaseCommon Stock 1,000 $8.95 $8,950.00
Disclosure

SEC source: 0001209191-19-047582 · doc4a.xml · nonDerivative · entry 5

Plavan Matthew T · CIK 0001326765 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,000

Read SEC document
August 27, 2019 Filed Aug 28, 2019 17:01 UTC Amendment
Plavan Matthew TChief Financial Officer
PurchaseCommon Stock 1,000 $9.30 $9,300.00
Disclosure

SEC source: 0001209191-19-047582 · doc4a.xml · nonDerivative · entry 4

Plavan Matthew T · CIK 0001326765 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,000

Read SEC document
August 27, 2019 Filed Aug 28, 2019 17:01 UTC Amendment
Plavan Matthew TChief Financial Officer
PurchaseCommon Stock 1,000 $9.32 $9,320.00
Disclosure

SEC source: 0001209191-19-047582 · doc4a.xml · nonDerivative · entry 3

Plavan Matthew T · CIK 0001326765 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,000

Read SEC document
August 27, 2019 Filed Aug 28, 2019 14:31 UTC
Plavan Matthew TChief Financial Officer
GrantCommon Stock 2,000 $8.93 $17,860.00
Disclosure

SEC source: 0001209191-19-047580 · doc4.xml · nonDerivative · entry 6

Plavan Matthew T · CIK 0001326765 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,000

Read SEC document
August 27, 2019 Filed Aug 28, 2019 14:31 UTC
Plavan Matthew TChief Financial Officer
GrantCommon Stock 1,000 $8.95 $8,950.00
Disclosure

SEC source: 0001209191-19-047580 · doc4.xml · nonDerivative · entry 5

Plavan Matthew T · CIK 0001326765 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,000

Read SEC document
August 27, 2019 Filed Aug 28, 2019 14:31 UTC
Plavan Matthew TChief Financial Officer
GrantCommon Stock 1,000 $9.30 $9,300.00
Disclosure

SEC source: 0001209191-19-047580 · doc4.xml · nonDerivative · entry 4

Plavan Matthew T · CIK 0001326765 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,000

Read SEC document
August 27, 2019 Filed Aug 28, 2019 14:31 UTC
Plavan Matthew TChief Financial Officer
GrantCommon Stock 1,000 $9.32 $9,320.00
Disclosure

SEC source: 0001209191-19-047580 · doc4.xml · nonDerivative · entry 3

Plavan Matthew T · CIK 0001326765 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,000

Read SEC document
August 26, 2019 Filed Aug 28, 2019 17:01 UTC Amendment
Plavan Matthew TChief Financial Officer
PurchaseCommon Stock 1,000 $9.22 $9,220.00
Disclosure

SEC source: 0001209191-19-047582 · doc4a.xml · nonDerivative · entry 2

Plavan Matthew T · CIK 0001326765 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,000

Read SEC document
August 26, 2019 Filed Aug 28, 2019 17:01 UTC Amendment
Plavan Matthew TChief Financial Officer
PurchaseCommon Stock 1,000 $8.33 $8,330.00
Disclosure

SEC source: 0001209191-19-047582 · doc4a.xml · nonDerivative · entry 1

Plavan Matthew T · CIK 0001326765 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,000

Read SEC document
August 26, 2019 Filed Aug 28, 2019 14:31 UTC
Plavan Matthew TChief Financial Officer
GrantCommon Stock 1,000 $9.22 $9,220.00
Disclosure

SEC source: 0001209191-19-047580 · doc4.xml · nonDerivative · entry 2

Plavan Matthew T · CIK 0001326765 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,000

Read SEC document
August 26, 2019 Filed Aug 28, 2019 14:31 UTC
Plavan Matthew TChief Financial Officer
GrantCommon Stock 1,000 $8.33 $8,330.00
Disclosure

SEC source: 0001209191-19-047580 · doc4.xml · nonDerivative · entry 1

Plavan Matthew T · CIK 0001326765 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,000

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.